{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:04:26Z","timestamp":1782889466574,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T00:00:00Z","timestamp":1235692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1038\/hr.2009.2","type":"journal-article","created":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T09:42:24Z","timestamp":1235727744000},"page":"261-264","source":"Crossref","is-referenced-by-count":13,"title":["Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction"],"prefix":"10.1038","volume":"32","author":[{"given":"Hiroko","family":"Hanasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Fukuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Katsuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Awata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Ogihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,27]]},"reference":[{"key":"BFhr20092_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/01.CIR.95.2.320","volume":"95","author":"A Saraste","year":"1997","unstructured":"Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM . Apoptosis in human acute myocardial infarction. Circulation 1997; 95: 320\u2013323.","journal-title":"Circulation"},{"key":"BFhr20092_CR2","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1161\/01.CIR.91.11.2703","volume":"91","author":"JM Isner","year":"1995","unstructured":"Isner JM, Kearney M, Bortman S, Passeri J . Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91: 2703\u20132711.","journal-title":"Circulation"},{"key":"BFhr20092_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/01.RES.87.3.184","volume":"87","author":"K Walsh","year":"2000","unstructured":"Walsh K, Smith RC, Kim HS . Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ Res 2000; 87: 184\u2013188.","journal-title":"Circ Res"},{"key":"BFhr20092_CR4","first-page":"367","volume":"149","author":"S Bjorkerud","year":"1996","unstructured":"Bjorkerud S, Bjorkerud B . Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 1996; 149: 367\u2013380.","journal-title":"Am J Pathol"},{"key":"BFhr20092_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1098\/rstb.1994.0107","volume":"345","author":"S Nagata","year":"1994","unstructured":"Nagata S . Apoptosis regulated by a death factor and its receptor: Fas ligand and Fas. Philos Trans R Soc Lond B Biol Sci 1994; 345: 281\u2013287.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFhr20092_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","volume":"88","author":"S Nagata","year":"1997","unstructured":"Nagata S . Apoptosis by death factor. Cell 1997; 88: 355\u2013365.","journal-title":"Cell"},{"key":"BFhr20092_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0092-8674(91)90614-5","volume":"66","author":"N Itoh","year":"1991","unstructured":"Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S . The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233\u2013243.","journal-title":"Cell"},{"key":"BFhr20092_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/blood.V98.1.194","volume":"98","author":"SE Straus","year":"2001","unstructured":"Straus SE, Jaffe ES, Puck JM, Dale JK, Elkon KB, R\u00f6sen-Wolff A, Peters AM, Sneller MC, Hallahan CW, Wang J, Fischer RE, Jackson CM, Lin AY, B\u00e4umler C, Siegert E, Marx A, Vaishnaw AK, Grodzicky T, Fleisher TA, Lenardo MJ . The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001; 98: 194\u2013200.","journal-title":"Blood"},{"key":"BFhr20092_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1172\/JCI5121","volume":"103","author":"AK Vaishnaw","year":"1999","unstructured":"Vaishnaw AK, Orlinick JR, Chu JL, Krammer PH, Chao MV, Elkon KB . The molecular basis for apoptotic defects in patients with CD95 (Fas\/Apo-1) mutations. J Clin Invest 1999; 103: 355\u2013363.","journal-title":"J Clin Invest"},{"key":"BFhr20092_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"1995","unstructured":"Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM . Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935\u2013946.","journal-title":"Cell"},{"key":"BFhr20092_CR11","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1126\/science.7539157","volume":"268","author":"F Rieux-Laucat","year":"1995","unstructured":"Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP . Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268: 1347\u20131349.","journal-title":"Science"},{"key":"BFhr20092_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0888-7543(05)80200-9","volume":"14","author":"J Inazawa","year":"1992","unstructured":"Inazawa J, Itoh N, Abe T, Nagata S . Assignment of the human Fas antigen gene (Fas) to 10q24.1. Genomics 1992; 14: 821\u2013822.","journal-title":"Genomics"},{"key":"BFhr20092_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0161-5890(97)00081-3","volume":"34","author":"QR Huang","year":"1997","unstructured":"Huang QR, Morris D, Manolios N . Identification and characterization of polymorphisms in the promoter region of the human Apo-1\/Fas (CD95) gene. Mol Immunol 1997; 34: 577\u2013582.","journal-title":"Mol Immunol"},{"key":"BFhr20092_CR14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4049\/jimmunol.154.3.1239","volume":"154","author":"J Cheng","year":"1995","unstructured":"Cheng J, Liu C, Koopman WJ, Mountz JD . Characterization of human Fas gene. Exon\/intron organization and promoter region. J Immunol 1995; 154: 1239\u20131245.","journal-title":"J Immunol"},{"key":"BFhr20092_CR15","first-page":"1183","volume":"29","author":"S Kanemitsu","year":"2002","unstructured":"Kanemitsu S, Ihara K, Saifddin A, Otsuka T, Takeuchi T, Nagayama J, Kuwano M, Hara T . A functional polymorphism in fas (CD95\/APO-1) gene promoter associated with systemic lupus erythematosus. J Rheumatol 2002; 29: 1183\u20131188.","journal-title":"J Rheumatol"},{"key":"BFhr20092_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1189\/jlb.0407198","volume":"83","author":"L Farre","year":"2008","unstructured":"Farre L, Bittencourt AL, Silva-Santos G, Almeida A, Silva AC, Decanine D, Soares GM, Alcantara Jr LC, Van Dooren S, Galv\u00e3o-Castro B, Vandamme AM, Van Weyenbergh J . Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia. J Leukoc Biol 2008; 83: 220\u2013222.","journal-title":"J Leukoc Biol"},{"key":"BFhr20092_CR17","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1172\/JCI3531","volume":"102","author":"M Sata","year":"1998","unstructured":"Sata M, Walsh K . Oxidized LDL activates fas-mediated endothelial cell apoptosis. J Clin Invest 1998; 102: 1682\u20131689.","journal-title":"J Clin Invest"},{"key":"BFhr20092_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm0498-415","volume":"4","author":"M Sata","year":"1998","unstructured":"Sata M, Walsh K . TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat Med 1998; 4: 415\u2013420.","journal-title":"Nat Med"},{"key":"BFhr20092_CR19","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.4049\/jimmunol.160.8.4042","volume":"160","author":"T Suhara","year":"1998","unstructured":"Suhara T, Fukuo K, Sugimoto T, Morimoto S, Nakahashi T, Hata S, Shimizu M, Ogihara T . Hydrogen peroxide induces up-regulation of Fas in human endothelial cells. J Immunol 1998; 160: 4042\u20134047.","journal-title":"J Immunol"},{"key":"BFhr20092_CR20","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/01.HYP.0000127914.94292.76","volume":"43","author":"T Suhara","year":"2004","unstructured":"Suhara T, Fukuo K, Yasuda O, Tsubakimoto M, Takemura Y, Kawamoto H, Yokoi T, Mogi M, Kaimoto T, Ogihara T . Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways. Hypertension 2004; 43: 1208\u20131213.","journal-title":"Hypertension"},{"key":"BFhr20092_CR21","doi-asserted-by":"publisher","first-page":"C504","DOI":"10.1152\/ajpcell.2000.279.2.C504","volume":"279","author":"T Niinobu","year":"2000","unstructured":"Niinobu T, Fukuo K, Yasuda O, Tsubakimoto M, Mogi M, Nishimaki H, Morimoto S, Ogihara T . Negative feedback regulation of activated macrophages via Fas-mediated apoptosis. Am J Physiol Cell Physiol 2000; 279: C504\u2013C509.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFhr20092_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0735-1097(01)01800-9","volume":"39","author":"M Shimizu","year":"2002","unstructured":"Shimizu M, Fukuo K, Nagata S, Suhara T, Okuro M, Fujii K, Higashino Y, Mogi M, Hatanaka Y, Ogihara T . Increased plasma levels of the soluble form of Fas ligand in patients with acute myocardial infarction and unstable angina pectoris. J Am Coll Cardiol 2002; 39: 585\u2013590.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr20092_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1291\/hypres.29.217","volume":"29","author":"N Kotani","year":"2006","unstructured":"Kotani N, Fukuo K, Yasuda O, Katuya T, Takemura Y, Kawamoto H, Yokoi T, Suzuki A, Ogihara T . Fas ligand mRNA levels of circulating leukocytes reflect endothelial dysfunction in hyperlipidemic but not in non-hyperlipidemic patients. Hypertens Res 2006; 29: 217\u2013225.","journal-title":"Hypertens Res"},{"issue":"Suppl 1","key":"BFhr20092_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000213884","volume":"43","author":"K Fukuo","year":"1997","unstructured":"Fukuo K, Nakahashi T, Nomura S, Hata S, Suhara T, Shimizu M, Tamatani M, Morimoto S, Kitamura Y, Ogihara T . Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis. Gerontology 1997; 43 (Suppl 1): 35\u201342.","journal-title":"Gerontology"},{"key":"BFhr20092_CR25","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/nm1459","volume":"12","author":"MC Clarke","year":"2006","unstructured":"Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR . Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006; 12: 1075\u20131080.","journal-title":"Nat Med"},{"key":"BFhr20092_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00011-005-1377-2","volume":"54","author":"ML Leon","year":"2005","unstructured":"Leon ML, Zuckerman SH . Gamma interferon: a central mediator in atherosclerosis. Inflamm Res 2005; 54: 395\u2013411.","journal-title":"Inflamm Res"},{"key":"BFhr20092_CR27","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1172\/JCI119465","volume":"99","author":"S Gupta","year":"1997","unstructured":"Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C . IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997; 99: 2752\u20132761.","journal-title":"J Clin Invest"},{"key":"BFhr20092_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/01.ATV.0000059419.11002.6E","volume":"23","author":"C Buono","year":"2003","unstructured":"Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW, Lichtman AH . Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 2003; 23: 454\u2013460.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr20092_CR29","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","volume":"157","author":"SC Whitman","year":"2000","unstructured":"Whitman SC, Ravisankar P, Elam H, Daugherty A . Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E\u2212\/\u2212 mice. Am J Pathol 2000; 157: 1819\u20131824.","journal-title":"Am J Pathol"},{"key":"BFhr20092_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1291\/hypres.30.259","volume":"30","author":"M Koga","year":"2007","unstructured":"Koga M, Kai H, Yasukawa H, Kato S, Yamamoto T, Kawai Y, Kusaba K, Seki Y, Kai M, Egashira K, Kataoka Y, Imaizumi T . Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice. Hypertens Res 2007; 30: 259\u2013267.","journal-title":"Hypertens Res"},{"key":"BFhr20092_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","volume":"15","author":"U Boehm","year":"1997","unstructured":"Boehm U, Klamp T, Groot M, Howard JC . Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15: 749\u2013795.","journal-title":"Annu Rev Immunol"},{"key":"BFhr20092_CR32","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.2353\/ajpath.2006.050473","volume":"168","author":"D Rosner","year":"2006","unstructured":"Rosner D, Stoneman V, Littlewood T, McCarthy N, Figg N, Wang Y, Tellides G, Bennett M . Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanism. Am J Pathol 2006; 168: 2054\u20132063.","journal-title":"Am J Pathol"},{"key":"BFhr20092_CR33","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1161\/ATVBAHA.107.155143","volume":"28","author":"MM Kavurma","year":"2008","unstructured":"Kavurma MM, Tan NY, Bennett MR . Death receptors and their ligands in atherosclerosis. Arterioscler Thromb Vasc Biol 2008; 28: 1694\u20131702.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr20092_CR34","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1161\/01.HYP.0000120124.27641.03","volume":"43","author":"Y Takemura","year":"2004","unstructured":"Takemura Y, Fukuo K, Yasuda O, Inoue T, Inomata N, Yokoi T, Kawamoto H, Suhara T, Ogihara T . Fas signaling induces Akt activation and upregulation of endothelial nitric oxide synthase expression. Hypertension 2004; 43: 880\u2013884.","journal-title":"Hypertension"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr20092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr20092","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr20092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T05:42:54Z","timestamp":1684906974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr20092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,27]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["BFhr20092"],"URL":"https:\/\/doi.org\/10.1038\/hr.2009.2","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,27]]}}}